CLVSF (CellaVision AB) Total Operating Expense : $29.42 Mil (TTM As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is CellaVision AB Total Operating Expense?

CellaVision AB's Total Operating Expense for the three months ended in Dec. 2024 was $7.08 Mil. CellaVision AB's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was $29.42 Mil.

CellaVision AB Total Operating Expense Historical Data

The historical data trend for CellaVision AB's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Total Operating Expense Chart

CellaVision AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Operating Expense

Get a 7-Day Free Trial

24.25

25.26

26.99

28.86

28.17

CellaVision AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Operating Expense	Get a 7-Day Free Trial															7.15	7.04	7.19	8.10	7.08

CellaVision AB Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $29.42 Mil.

CellaVision AB Total Operating Expense Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

CellaVision AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OTCPK:CLVSF) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

CEVI:Sweden 0MR5:UK C26:Germany

Address

Mobilvagen 12, Lund, SWE, 22362

Website

https://www.cellavision.com

CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers/software.